Ken Griffin Arcadia Biosciences, Inc. Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.26 - $22.56 $47,173 - $4.09 Million	181,437 New	181,437 $48,000
Q2 2022 Aug 15, 2022	BUY	$0.83 - $1.61 $19,165 - $37,176	23,091 Added 67.93%	57,081 $58,000
Q1 2022 May 16, 2022	SELL	$0.78 - $2.62 $23,877 - $80,203	-30,612 Reduced 47.39%	33,990 $48,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.11 $64,602 - $136,310	64,602 New	64,602 $67,000
Q2 2020 Aug 14, 2020	SELL	$2.74 - $5.06 $31,329 - $57,856	-11,434 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.37 - $5.76 $27,098 - $65,859	11,434 New	11,434 $33,000
Q4 2019 Feb 14, 2020	SELL	$4.09 - $6.44 $67,644 - $106,511	-16,539 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.92 - $9.85 $11,543 - $59,218	6,012 Added 57.11%	16,539 $77,000
Q2 2019 Aug 14, 2019	BUY	$3.07 - $7.43 $32,317 - $78,215	10,527 New	10,527 $32,000

Ticker RKDA
Exchange NASDAQ
Sector Basic Materials
Industry Agricultural Inputs
Shares Outstandng 24,643,000
Market Cap $69.5M
Description
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.